Treatment of Alcohol Dependence With Drug Antagonists of the Stress Response

Alcohol Research: Current Reviews

Volumn 34, Issue 4, 2012, Pages 516-521

  Higley, Amanda E ^a   Koob, George F ^a   Mason, Barbara J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alcohol dependence; Alcohol use disorder; Alcoholism; Antagonists; Brain; Negative affective states; Neurochemistry; Pharmacotherapy; Relapse prevention; Stress; Stress response; relapse; Treatment; neuroadaptation

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DYNORPHIN; KAPPA OPIATE RECEPTOR; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE Y;

ALCOHOLISM; ARTICLE; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; MENTAL STRESS; RECURRENT DISEASE;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ALCOHOLISM; DYNORPHINS; HUMANS; NEUROPEPTIDE Y; NEUROTRANSMITTER AGENTS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, NEUROKININ-1; RECEPTORS, OPIOID, KAPPA; RECURRENCE; STRESS, PSYCHOLOGICAL;

MLCS; MLOWN;

EID: 84870045596     PISSN: 15357414     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Aguíar, M.S., and Brandao, M.L. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test. Physiology & Behavior 60(4):1183-1186, 1996. PMID:8884951
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000.
3. Baldwin, H.A.; Rassnick, S.; Rivier, J. et al. CRF antagonist reverses the anxiogenic response to ethanol withdrawal in the rat. Psychopharmacology 103(2):227-232, 1991. PMID: 2027923
4. Berman, J.D.; Cook, D.M.; Buchman, M.; and Keith, L.D. Diminished adrenocorticotropin response to insulin- induced hypoglycemia in nondepressed, actively drinking male alcoholics. Journal of Clinical Endocrinology and Metabolism 71(3):712-717, 1990. PMID: 2168434
5. Bernardy, N.C.; King, A.C.; Parsons, O.A.; and Lovallo, W.R. Altered cortisol response in sober alcoholics: An examination of contributing factors. Alcohol 13(5): 493-498, 1996. PMID: 8888947
6. Blomeyer, D.; Treutlein, J.; Esser, G. et al. Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biological Psychiatry 63(2):146-151, 2008. PMID: 17597588
7. Britton, K.T.; Southerland, S.; Van Uden, E. et al. Anxiolytic activity of NPY receptor agonists in the conflict test. Psychopharmacology 132(1):6-13, 1997. PMID: 9272753
8. Broqua, P.; Wettstein, J.G.; Rocher, M.N. et al. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behavioural Pharmacology 6(3):215-222, 1995. PMID: 11224329
9. Chavkin, c., James, I.F., and Goldstein, A. (1982). Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215(4531):413-415, 1982. PMID:6120570
10. Cippitelli, A.; Damadzic, R.; Frankola, K. et al. Alcohol- induced neurodegeneration, suppression of transforming growth factor-beta, and cognitive impairment in rats: Prevention by group II metabotropic glutamate receptor activation. Biological Psychiatry 67(9):823-830, 2010. PMID: 20132926
11. Clinicaltrials.gov. Clinical trial of the adrenergic alpha-1 antagonist prazosin for alcohol dependence, 2010. Clinical trial reg. no. nCt00762710, clinicaltrials.gov.
12. Clinicaltrials.gov. The effect of nK1 r antagonism on alcohol craving and PtSD symptoms in alcohol dependent patients with PtSD, 2009. Clinical trial reg. no. nCt00896038, clinicaltrials.gov.
13. Clinicaltrials.gov. Effects of corticotropin-releasing hormone receptor 1 (CrH1) antagonism on stress-induced craving in alcoholic women with high anxiety: An experimental medicine study, 2010. Clinical trial reg. no. nCt01187511, clinicaltrials.gov.
14. Clinicaltrials.gov. Corticotropin-releasing hormone receptor 1 (CrH 1) antagonism in anxious alcoholics, 2011. Clinical trial reg. no. nCt01227980, clinicaltrials.gov
15. Commons, K.G. Neuronal pathways linking substance P to drug addiction and stress. Brain Research 1314: 175182, 2010. PMID: 19913520
16. Doyon, W.M., Howard, E.C., Shippenberg, T.S., and Gonzales, R.A., Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration. Neuropharmacology 51(3):487-496, 2006. PMID: 16781738
17. Ebner, K.; Sartori, S.B.; and Singewald, N. Tachykinin receptors as therapeutic targets in stress-related disorders. Current Pharmaceutical Design 15(14):1647-1674, 2009. PMID: 19442179
18. Ebner, K., and Singewald, N. The role of substance P in stress and anxiety responses. Amino Acids 31(3):251-272, 2006. PMID: 16820980
19. Ehlers, C.L.; Somes, C.; and Cloutier, D. Are some of the effects of ethanol mediated through NPY? Psychopharmacology 139(1-2):136-144, 1998. PMID: 9768551
20. Ehrenreich, H.; Schuck, J.; Stender, N.; etal. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcoholism: Clinical and Experimental Research 21(7): 1285-1293, 1997. PMID: 9347091
21. Elliott, P.J. Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: Implication of substance P in aversion. Experimental Brain Research 73(2):354-356, 1988. PMID: 2463935
22. Errico, A.L.; Parsons, o.A.; King, A.C.; and Lovallo, W.R. Attenuated cortisol response to biobehavioral stressors in sober alcoholics. Journal of Studies on Alcohol 54(4):393-398, 1993. PMID: 8341041
23. Funk, C.K., and Koob, G.F. A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Research 1155:172-178, 2007. PMID: 17512918
24. Funk, C.K.; o'Dell, L.E.; Crawford, E.F.; and Koob, G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol selfadministration in withdrawn, ethanol-dependent rats. Journal of Neuroscience 26(44):11324-11332, 2006. PMID: 17079660
25. George, D.T.; Gilman, J.; Hersh, J.; etal. Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 319(5869):1536-1539, 2008. PMID: 19276852
26. Gilpin, N.W.; Misra, K.; and Koob, G.F. Neuropeptide Y in the central nucleus of the amygdala suppresses dependence- induced increases in alcohol drinking. Pharmacology, Biochemistry, and Behavior 90(3):475-480, 2008. PMID: 18501411
27. Hasin, D.S.; Stinson, F.S.; ogburn, e.; and Grant, B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 64(7):830-842, 2007. PMID: 17606817
28. Heilig, M., and Koob, G.F. A key role for corticotropin- releasing factor in alcohol dependence. Trends in Neurosciences 30(8):399-406, 2007. PMID: 17629579
29. Heilig, M.; McLeod, S.; Brot, M. et al. Anxiolytic-like action of neuropeptide Y: Mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8(4):357-363, 1993. PMID: 8099792
30. Heilig, M., and Thorsell, A. Brain neuropeptide Y (NPY) in stress and alcohol dependence. Reviews in the Neurosciences 13(1):85-94, 2002. PMID: 12013027
31. Heinrichs, S.C., and Koob, G.F. Corticotropin-releasing factor in brain: A role in activation, arousal, and affect regulation. Journal of Pharmacology and Experimental Therapeutics 311(2):427-440, 2004. PMID: 15297468
32. Higley, A.E.; Crane, N.A.; Spadoni, A.D.; et al. Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals. Psychopharmacology 218(1):121-129, 2011. PMiD: 21607563
33. Hwang, B.H.; Suzuki, R.; Lumeng, L. et al. Innate differences in neuropeptide Y (NPY) mRNA expression in discrete brain regions between alcohol-preferring (P) and - nonpreferring (NP) rats: A significantly low level of NPY mRNA in dentate gyrus of the hippocampus and absence of NPY mRNA in the medial habenular nucleus of P rats. Neuropeptides 38(6):359-368, 2004. PMID: 15567472
34. Hwang, B.H.; Zhang, J.K.; Ehlers, C.L. et al. Innate differences of neuropeptide Y (NPY) in hypothalamic nuclei and central nucleus of the amygdala between selectively bred rats with high and low alcohol preference. Alcoholism: Clinical and Experimental Research 23(6):1023-1030, 1999. PMID: 10397286
35. Junghanns, K.; Backhaus, J.; Tietz, U. et al. Impaired serum cortisol stress response is a predictor of early relapse. Alcohol and Alcoholism 38(2):189-193, 2003. PMID:12634269
36. Koob G.F. Alcoholism: Allostasis and beyond. Alcoholism: Clinical and Experimental Research 27(2):232-243, 2003. PMID: 12605072
37. Koob G.F. A role for brain stress systems in addiction. Neuron 59(1):11-34, 2008. PMID: 18614026
38. Koob, G.F., and Le Moal, M. Drug abuse: Hedonic homeostatic dysregulation. Science 278(5335):52-58, 1997. PMID: 9311926
39. Koob, G.F., and VOLKOW, N.D. Neurocircuitry of addiction. Neuropsychopharmacology 35(1):217-238, 2010. PMID:19710631
40. Kovacs, K.M.; Szakall, i.; O'brien, D. et al. Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcoholism: Clinical and Experimental Research 29(5):730-738, 2005. PMID: 15897716
41. Land, B.B.; Bruchas, M.R.; Lemos, J.C.; etal. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. Journal of Neuroscience 28(2):407-414, 2008. PMID: 18184783
42. Le, A.D.; Harding, S.; Juzytsch, W. et al. The role of corti- cotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology 150(3):317-324, 2000. PMID: 10923760
43. Lindholm, S.; Ploj, K.; Franck, J.; and Nylander, I. Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. Alcohol 22(3):165-171, 2000. PMiD: 11163124
44. Liu, X., and Weiss, F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: Exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. Journal of Neuroscience 22(18):7856-7861, 2002. PMiD: 12223538
45. Lovallo, W.R.; Dickensheets, S.L.; Myers, D.A. et al. Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcoholism: Clinical and Experimental Research 24(5):651-658, 2000. PMID:10832906
46. Mason, B.J.; Light, J.M.; Escher, T.; and Drobes, D.J. Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics. Psychopharmacology (Berlin) 200(1): 141-150, 2008. PMID: 18604601
47. Menkes, D.B.; Baraban, J.M.; and Aghajanian, G.K. Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain. Naunyn-Schmiedeberg's Archives of Pharmacology 317(3):273-275, 1981. PMID: 6119624
48. Merlo Pich, E.; Lorang, M.; Yeganeh, M. et al. increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. Journal of Neuroscience 15(8):5439-5447, 1995. PMID: 7643193
49. Mucha, R.F., and Herz, A. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berlin) 86(3):274-280, 1985. PMID: 2994144
50. olive, M.F.; Koenig, H.N.; Nannini, M.A.; and Hodge, C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacology, Biochemistry, and Behavior 72(1-2):213-220, 2002. PMID:11900791
51. Pfeiffer, A.; Brantl, V.; Herz, A.; and Emrich, H.M. Psychotomimesis mediated by kappa opiate receptors. Science 233(4765):774-776, 1986. PMID: 3016896
52. Ploj, K.; Roman, E.; Gustavsson, L.; and Nylander, I. Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice. Biain Research Bulletin 53(2):219-226, 2000. PMID: 11044599
53. Rasmussen, D.D.; Alexander, L.L.; Raskind, M.A.; and Froehlich, J.C. The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats. Alcoholism: Clinical and Experimental Research 33(2):264-272, 2009. PMID: 19032582
54. Riihioja, P.; Jaatinen, P.; Oksanen, H. et al. Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat. Alcohol 14(6):537-544, 1997. PMID: 9401667
55. Rosin, A.; Lindholm, S.; Franck, J.; and Georgieva, J. Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens. Neuroscience Letters 275(1):1-4, 1999. PMID: 10554970
56. Roy, A., and Pandey, S.C. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcoholism: Clinical and Experimental Research 26(6):796-803, 2002. PMID: 12068247
57. Shippenberg, T.S.; Zapata, A.; and Chefer, v.i. Dynorphin and the pathophysiology of drug addiction. Pharmacology & Therapeutics 116(2):306-321, 2007. PMID: 17868902
58. Shirayama, Y.; Ishida, H.; Iwata, M. et al. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. Journal of Neurochemistry 90(5):1258-1268, 2004. PMID: 15312181
59. Simpson, T.L.; Saxon, A.J.; Meredith, C.W. et al. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence. Alcoholism: Clinical and Experimental Research 33(2):255-263, 2009. PMID: 18945226
60. Sinha, R.; Fox, H.C.; Hong, K.A. et al. Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 34(5):1198-1208, 2009. PMID: 18563062
61. Spanagel, R.; Herz, A.; and Shippenberg, T.S. Opposing ton- ically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America 89(6):2046-2050, 1992. PMID: 1347943
62. Substance Abuse and Mental Health Services Administration. Results from fhe 2008 National Survey on Drug Use and Health: National Findings. (office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434. Rockville, MD. 2009.
63. Teixeira, R.M.; Santos, A.R.; Ribeiro, S.J. et al. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. European Journal of Pharmacology 311(1):7-14, 1996. PMID:8884230
64. Thorsell, A. Neuropeptide Y (NPY) in alcohol intake and dependence. Peptides 28(2):480-483, 2007. PMID: 17239487
65. Thorsell, A.; Carlsson, K.; Ekman, R.; and Heilig, M. Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreporf 10(14):3003-3007, 1999. PMID: 10549813
66. Thorsell, A.; Schank, J.R.; Singley, E. et al. Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice. Psychopharmacology (Berlin) 209(1):103-111, 2010. PMID: 20112009
67. Todtenkopf, M.S.; Marcus, J.F.; Portoghese, P.S.; and Carlezon, W.A., Jr. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berlin) 172(4):463-470, 2004. PMID: 14727002
68. Treutlein, J.; Kissling, C.; Frank, J. et al. Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Molecular Psychiatry 11(6):594-602, 2006. PMID: 16550213
69. valdez, G.R.; Platt, D.M.; Rowlett, J.K. et al. Kappa gonist-induced reinstatement of cocaine seeking in squirrel monkeys: A role for opioid and stress-related mechanisms. Journal of Pharmacology and Experimental Therapeutics 323(2):525-533, 2007. PMID: 17702903
70. valdez, G.R.; Roberts, A.J.; Chan, K. et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: Regulation by corticotropin-releasing factor. Alcoholism: Clinical and Experimental Research 26(10):1494-1501, 2002. PMID: 12394282
71. Walker, B.M., and Koob, G.F. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33(3):643-652. PMID: 17473837
72. Walker, B.M.; Rasmussen, D.D.; Raskind, M.A.; Koob, G.F. Alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol 42(2):91-97, 2008. PMID: 18358987
73. Walker, B.M.; Zorrilla, E.P.; Koob, G.F. Systemic k{cyrillic}-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addiction Biology 16(1):116-119, 2011. PMID: 20579007
74. Wand, G.S., and Dobs, A.S. Alterations in the hypothalamic- pituitary-adrenal axis in actively drinking alcoholics. Journal of Clinical Endocrinology and Metabolism 72(6):1290-1295, 1991. PMID: 2026749
75. Zhang, H.; Sakharkar, A.J.; Shi, G. et al. Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol- preferring rats. Alcoholism: Clinical and Experimental Research 34(3):451-461, 2010. PMID: 20028368
76. Zorrilla, E.P.; valdez, G.R.; and Weiss, F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berlin) 158:374-381, 2001. PMID: 11797058